Green Thumb Indus Sub Vtg (OP:GTBIF)

6.550 -0.060 (-0.91%)

Delayed Quote Updated: 3:59 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Green Thumb Indus Sub Vtg

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

47 48 Next >

RYTHM Premium Cannabis Brings Back The Miracle in Mundelein Two-Day Festival with Legal On-site Cannabis Consumption

May 29, 2024

From Green Thumb Industries

Via GlobeNewswire

Cannabis Bargains: 3 Underappreciated Stocks to Snap Up in May 2024 ↗

May 28, 2024

Dive into the world of underappreciated cannabis stocks and profit from an industry poised for remarkable development.

Via InvestorPlace

Topics Cannabis

All 12 Constituents In The Cannabis Portfolios Declined W/e May 24th ↗

May 27, 2024

All 12 constituents declined w/e by an average of 14.4% and are now down 28.9%, on average, since Tuesday, April 30th, when the DEA announced it planned to reclassify cannabis as a less regulated...

Via Talk Markets

Topics Cannabis

The 2024 Millionaire’s Club: 7 Cannabis Stocks to Buy Now ↗

May 26, 2024

One of the hottest topics of the year has been cannabis stocks to buy, especially with elections nearing. Here are seven to consider.

Via InvestorPlace

Topics Cannabis

4 Unparalleled Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market ↗

May 25, 2024

Magnificent growth stocks at bargain prices can still be found, even with the Nasdaq Composite reaching a fresh all-time high.

Via The Motley Fool

Topics Stocks

$514M Tax Breaks Await This Marijuana Company With Rescheduling, Market Cap Set To Soar ↗

May 22, 2024

Jushi Holdings Inc. (OTC: JUSHF) is poised for substantial growth with potential adult-use cannabis legalization in Ohio and Pennsylvania as well as continuous expansion in Virginia’s medical market.

Via Benzinga

Topics Cannabis

3 Cannabis Stocks That Could Be Millionaire-Makers: May Edition ↗

May 22, 2024

Cannabis stocks to buy are surging after the DOJ proposed reclassifying marijuana, signaling a promising future.

Via InvestorPlace

Topics Cannabis

Ohio Medical Marijuana Companies Transition To Recreational Market, Sales Expected Soon ↗

May 21, 2024

Ohio's legal marijuana market is expected to significantly cut down on illicit sales by making it easier for Ohioans to access weed.

Via Benzinga

Topics Cannabis

Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments ↗

May 20, 2024

The trading volume of a stock reflects the number of shares bought and sold within a given time. This is called liquidity. The term is used because it likens the ease of converting assets to cash to...

Via Benzinga

Topics Cannabis

Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red? ↗

May 20, 2024

Four lesser-valued cannabis stocks showed positive performance on Monday, defying the broader sector's downtrend. These stocks—Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms...

Via Benzinga

Topics Cannabis

Bearish Monday For Marijuana Stocks - Flower One Hldgs, SOL Glb Inv Among Top Gainers ↗

May 20, 2024

Via Benzinga

Topics Cannabis

Is Tilray Brands Stock a Buy? ↗

May 20, 2024

Despite a broad rally in cannabis, this top Canadian LP has failed to join the party.

Via The Motley Fool

Topics Cannabis

Is Aurora Cannabis Stock a Buy? ↗

May 20, 2024

The company's cost-cutting initiative and pivot to medical cannabis could pay big dividends for patient shareholders.

Via The Motley Fool

Topics Cannabis

American Cannabis MSOs Portfolio Reversed Direction Last Week ↗

May 19, 2024

This article highlights how each constituent in the Portfolio fared last week and MTD along with their reported Q1 profit or loss and their Q1 adjusted EBITDA as a percentage of quarterly revenue for...

Via Talk Markets

Topics Cannabis

Medical Marijuana Campaign in Nebraska Meets Crucial Signature Requirement

May 17, 2024

Via CannabisNewsWire

Topics Cannabis

3 Cheap Cannabis Stocks to Buy Now: May 2024 ↗

May 15, 2024

With great growth potential and financials looking very positive, these three cannabis stocks are your best option for investment.

Via InvestorPlace

Topics Cannabis

Florida Cannabis Legalization Amendment Ads Hit Airwaves: The First 4 Pitches For Legal Weed In The Sunshine State ↗

May 14, 2024

The advocacy group's ads are being aired across the state over TV, radio, streaming and on digital sites. Having spent more than $5 million, the ads are criss-crossing the state to bring attention to...

Via Benzinga

Topics Cannabis

3 Companies to Watch as Nasdaq Warms Up to Cannabis Listings ↗

May 14, 2024

While it's uncertain if the Drug Enforcement Agency will reschedule marijuana, these are three cannabis stocks to watch if it does.

Via InvestorPlace

Topics Cannabis

Analysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37M ↗

May 14, 2024

Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state operators (MSOs). According to a recent report by Viridian Capital Advisors,...

Via Benzinga

Topics Cannabis

Here's Where To Buy Legal Weed: Florida's Thriving Cannabis Landscape And More New Marijuana Stores In US And Canada ↗

May 13, 2024

In anticipation of the outcome of Florida's Measure 3, cannabis giants are racing to bolster their retail footprint statewide. In California, four new cannabis stores kicked off sales recently. New...

Via Benzinga

Topics Cannabis

The 7 Most Undervalued Cannabis Stocks to Buy in May 2024 ↗

May 13, 2024

Some of the most undervalued cannabis stocks could race to higher highs on several key catalysts this year. Here are seven.

Via InvestorPlace

Topics Cannabis

American Cannabis MSOs Portfolio Down 5% On The Week ↗

May 11, 2024

Five of the 7 constituents released their Q1 financial reports earlier this week, contributing to a 5% decline in our portfolio for the week ending May 10.

Via Talk Markets

Topics Cannabis

Cannabis Stock Movers For May 9, 2024 ↗

May 09, 2024

Via Benzinga

Topics Cannabis

Medical Marijuana Giant Trulieve, Backer Of Florida's Recreational Cannabis Ballot, Narrows Loss, Reports Uptick In Q1 Revenue, Gross Profit ↗

May 09, 2024

Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahassee, Florida-based medical cannabis giant reported revenue of $298 million...

Via Benzinga

Topics Cannabis

GTBIF Stock Earnings: Green Thumb Industries Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

GTBIF stock results show that Green Thumb Industries beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Green Thumb Industries Revenue Increases 11% In Q1 2024: We're 'Off To A Great Start,' Says Pres ↗

May 08, 2024

'As we round out our tenth year as a company, we believe we have a clear vision, a healthy balance sheet and the best team in the business to execute the next decade of the Green Thumb story,' said CEO...

Via Benzinga

The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy? ↗

May 08, 2024

These top cannabis stocks by revenue are among the world's best sellers, making them prime investment opportunities to capture legal changes.

Via InvestorPlace

Topics Cannabis

Green Thumb Industries Reports First Quarter 2024 Results

May 08, 2024

From Green Thumb Industries

Via GlobeNewswire

Marijuana Stock Movers For May 7, 2024 ↗

May 07, 2024

Via Benzinga

Topics Cannabis

Big Players In U.S. Cannabis Could Play The Stock-Value Card In M&A, New Report Shows ↗

May 06, 2024

As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to

Via Benzinga

Topics Cannabis

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

47 48 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.